U.S. Patient with Advanced Lung Cancer Stabilized by Novel Immunotherapy Treatment in China

SHANGHAI, March 6, 2026 /PRNewswire/ — Jiahui International Cancer Center (JICC) has stabilized a U.S. patient with advanced non‑small cell lung cancer (NSCLC) and Parkinson’s disease using ivonescimab, a novel immunotherapy currently available only in China.

More Stories

Paladino strikes back, sues Council

As promised, Councilwoman Vickie Paladino (R-Whitestone) on Monday morning filed a lawsuit in Manhattan Superior Court to end disciplinary proceedings against her in the City Council.Paladino on March 2 was charged with engaging in disorderly behavior and violating the Council’s…

Read More »

Army Guard engineer dies in Middle East

A Cambria Heights man died overseas last Friday, leaving behind a wife and six kids, announced the New York Division of Military and Naval Affairs on Monday. New York Army National Guard Major Sorffly Davius, 46, died of undetermined causes…

Read More »